Abstract:BACKGROUND: Transanal total mesorectal excision is a promising surgical procedure for mid to low rectal cancer. OBJECTIVE: This study aimed to determine the short-term outcomes of Chinese patients treated with transanal total mesorectal excision. DESIGN: This was an observational study using data from an online registry system. SETTING: Study participants were recruited from 40 different centers across 15 provinces in China. PATIENTS: Patients with either benign or malignant rectal disease who underwent transanal total mesorectal excision procedure and were registered in the Chinese Transanal Total Mesorectal Excision Registry Collaborative from May 2010 to November 2019 were included. INTERVENTION: Patients underwent transanal total mesorectal excision. MAIN OUTCOME MEASURES: The primary outcomes measured were the postoperative complications and pathological outcomes. RESULTS: In total, 1283 patients, comprising 888 men (69.2%) and 395 women (39.8%) with a median age of 61 (22-92) years and a median BMI of 23.6 (14.5-46.3) kg/m(2), were analyzed. Among 40 participating centers, the average number of registered cases was 32.1 +/- 34.7, and 12 centers (30%) registered >40 cases in the registry. Among 849 patients with rectal cancer who underwent laparoscopic-assisted transanal total mesorectal excision, the conversion rate was 0.5% in the abdominal phase and 1.9% in the perineal phase. Three patients reported urethral injury (0.5%). The postoperative complication rate and the anastomotic leakage incidence were 18.4% and 5.8%. The quality of the total mesorectum excision specimens was found to be complete in 81.9% of patients. In addition, the positive circumferential resection margin rate was 2.8%. LIMITATIONS: The primary limitation of this registry study was the high percentage of missing data (10.8% overall), and, for some of the analyzed variables, up to 35% of the data was missing. Postoperative complications were not monitored after discharge, resulting in a lower morbidity rate than the 30-day morbidity rate reported in other studies. CONCLUSIONS: The short-term outcomes of patients who underwent transanal total mesorectal excision procedures in China were acceptable. See Video Abstract at http://links.lww.com/DCR/B414.

Conduct high-quality clinical studies in rectal cancer surgery based upon the IDEAL frame-work and recommendations

Standards of Surgical Clinical Researches: Introduction of IDEAL Framework

The application of laparoscopic total mesorectal excision with preservation of anal sphincter for rectal cancer

[Quality control of laparoscopic colorectal surgery].

Research Improvements and Related Hot Issues of Surgical Treatment on Locally Advanced Rectal Cancer

[Advances of minimally invasive technique in colorectal cancer surgery]

[The Development Process and New Requirements of Structured Training on Transanal Total Mesorectal Resection].

The surgical skills and outcomes evaluation of transanal total mesorectal excision

Surgical quality control of TME and ELAPE procedure for rectal cancer

Quality control in the surgery of rectal cancer

Transanal total mesorectal excision for rectal cancer: hype or new hope?

[Perceptions of transanal total mesorectal excision surgical quality and patient screening]

Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial

Transanal Total Mesorectal Excision: Short-term Outcomes of 1283 Cases from a Nationwide Registry in China.

Evolution of transanal total mesorectal excision for rectal cancer: From top to bottom

Actively participate in international high-quality clinical trials for improving the research level of colorectal surgery in China

[Current status and prospect of transanal total mesorectal excision].

Clinical Status and Future Prospects of Transanal Total Mesorectal Excision

[Transanal Total Mesorectal Excision in Laparoscopic Surgery for Lower Rectal Cancer: Leading Actor or Supporting Actor].

Futher discussion on the progress and controversy and prospect of the procedure of transanal total mesorectal excision

Robotic Total Mesorectal Excision for Rectal Cancer: A Series of 392 Cases and Mid-Term Outcomes from A Single Center in China